the main indications where combined rifampicin treatment led to favourable results were uti ( success rate 64.9 % ) , bone infections ( 86.9 % ) , staphylococcal endocarditis ( 85.0 % ) , respiratory tract infections often due to gram-negative rods ( 97.7 % ) as well as skin and soft tissue infections ( 83.3 % ) , and bacterial meningitis ( 100 % ) .
C0035608
rifampicin
C0085437
bacterial meningitis